Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
PRINCIPEN '250' vs PRINCIPEN '125'
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
Ampicillin is a penicillin beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis.
Infections caused by susceptible strains of Gram-positive and Gram-negative bacteria, including respiratory tract infections, urinary tract infections, meningitis, septicemia, and endocarditis,Off-label: Prophylaxis for bacterial endocarditis in dental procedures, treatment of listeriosis
Treatment of infections caused by susceptible gram-positive and gram-negative bacteria, including respiratory tract infections, otitis media, sinusitis, urinary tract infections, meningitis, septicemia, and gastroenteritis.,Off-label: Prophylaxis for bacterial endocarditis, treatment of listeriosis, and Lyme disease.
250 mg orally every 6 hours
250-500 mg orally every 6 hours for mild to moderate infections; 500 mg to 1 g every 6 hours for severe infections.
1.0-1.5 hours in normal renal function; prolongation in renal impairment requires dose adjustment
Terminal elimination half-life: 0.7-1.4 hours in adults with normal renal function. Prolonged in renal impairment (up to 7-10 hours in anuria).
Ampicillin is primarily excreted unchanged by the kidneys via glomerular filtration and tubular secretion. Some hepatic metabolism occurs, but it is minimal.
Ampicillin is metabolized by hydrolysis to penicilloic acid, primarily in the liver. It also undergoes renal tubular secretion.
Primarily renal (60-80% unchanged), with some biliary/fecal excretion (approximately 10-20%)
Renal: approximately 60-80% of the dose excreted unchanged in urine via tubular secretion and glomerular filtration. Biliary/fecal: minimal, <10%.
20-25% bound to serum albumin
Approximately 20-30% bound to serum proteins, primarily albumin.
0.2-0.3 L/kg, indicating limited extravascular distribution
0.3-0.4 L/kg, approximating extracellular fluid volume. Higher in neonates and critically ill patients due to increased extracellular water.
Oral: 25-40% (acid-labile, food reduces absorption)
Oral: 30-50% due to acid lability and incomplete absorption. IM: nearly 100%.
Cr Cl 10-50 m L/min: 250 mg every 12-24 hours; Cr Cl <10 m L/min: 250 mg every 24-48 hours
Cr Cl 10-50 m L/min: Administer every 6-12 hours. Cr Cl <10 m L/min: Administer every 12-16 hours.
No dosage adjustment required for mild to moderate hepatic impairment. Severe impairment (Child-Pugh C): reduce dose by 50% or extend interval to every 12 hours
No dose adjustment required.
Children >1 month: 12.5-25 mg/kg orally every 6 hours; maximum 4 g/day
Infants and children: 12.5-25 mg/kg orally every 6 hours. For severe infections: up to 50 mg/kg/day in divided doses every 6 hours.
Monitor renal function; adjust dose based on Cr Cl as for adults with renal impairment. Avoid in elderly with Cr Cl <10 m L/min unless necessary.
Dose based on renal function; use lower end of dosing interval due to age-related decline in renal function.
No FDA black box warning.
No FDA black box warning.
Serious and occasionally fatal hypersensitivity reactions (anaphylaxis) have been reported; contraindicated in patients with penicillin allergy.,Clostridium difficile-associated diarrhea (CDAD) can occur and may range in severity from mild diarrhea to fatal colitis.,Prolonged use may result in overgrowth of nonsusceptible organisms, including fungi; superinfection may occur.,Use with caution in patients with renal impairment; dosage adjustment may be necessary.,Cases of drug-induced hepatitis and cholestatic jaundice have been reported.
Serious and occasionally fatal hypersensitivity reactions (anaphylaxis) have occurred.,Clostridium difficile-associated diarrhea (CDAD) reported with nearly all antibacterial agents.,Prolonged use may result in overgrowth of nonsusceptible organisms including fungi.,Dosage adjustment required in renal impairment.,Safety in pregnancy: Category B; use only if clearly needed.
History of allergic reaction to any penicillin,Infections caused by penicillinase-producing organisms
Hypersensitivity to penicillins, cephalosporins, or other beta-lactam antibiotics.,Infections caused by beta-lactamase-producing organisms (ampicillin is susceptible to beta-lactamase degradation).
Food significantly reduces ampicillin absorption. Avoid taking with meals, dairy products, or acidic beverages (e.g., orange juice). Metal ions (calcium, iron, zinc) and antacids chelate ampicillin, reducing bioavailability. Alcohol does not directly interact but may increase risk of gastrointestinal upset.
Take on an empty stomach. Food, especially acidic beverages or fruit juices, may reduce absorption. Avoid alcohol concurrently. No specific dietary restrictions.
FDA Pregnancy Category B. Animal studies show no fetal risk, but no adequate human studies in first trimester. No known teratogenicity; use during pregnancy only if clearly needed.
FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. Inadequate human data in first trimester; risk cannot be excluded. Penicillins are generally considered low risk throughout pregnancy.
Ampicillin is excreted in breast milk in low concentrations. M/P ratio approximately 0.1-0.2. Considered compatible with breastfeeding by American Academy of Pediatrics; monitor infant for diarrhea and candidiasis.
Excreted into breast milk in low amounts (M/P ratio approximately 0.5). Considered compatible with breastfeeding; monitor infant for rash, diarrhea, or candidiasis.
Increased plasma volume and renal clearance during pregnancy may reduce serum ampicillin concentrations. No routine dose adjustment recommended, but for serious infections, doses at the higher end of the usual range may be considered. Monitor therapeutic response.
No significant pharmacokinetic changes requiring dose adjustment. Increased renal clearance and expanded plasma volume may lower serum concentrations, but standard dosing remains effective. Adjust only if renal function significantly declines.
Principen '250' (ampicillin) is a penicillinase-sensitive aminopenicillin with activity against Gram-positive cocci (except penicillinase-producing staphylococci) and some Gram-negative bacilli. Key pearls: (1) Administer on an empty stomach (1 hour before or 2 hours after meals) to enhance absorption; (2) Monitor for maculopapular rash, especially in patients with infectious mononucleosis or cytomegalovirus infection, where incidence approaches 70-100%; (3) Dose adjustment required in renal impairment (Cr Cl <30 m L/min); (4) Use caution in patients with history of hypersensitivity to penicillins or cephalosporins; (5) Not effective against penicillin-resistant Streptococcus pneumoniae; (6) Consider drug fever or serum sickness-like reactions as adverse effects.
Principen '125' (ampicillin) is a broad-spectrum penicillin. Note that it is inactivated by beta-lactamases; use with a beta-lactamase inhibitor for resistant organisms. Administer on an empty stomach (1 hour before or 2 hours after meals) for optimal absorption. Monitor for hypersensitivity reactions, especially rash; ampicillin rash is common in patients with Epstein-Barr virus or concurrent allopurinol use. Adjust dose in renal impairment (Cr Cl <30 m L/min).
Take this medication exactly as prescribed, at evenly spaced times, and finish the full course even if you feel better.,Take on an empty stomach, at least 1 hour before or 2 hours after meals, with a full glass of water.,Do not take with antacids, laxatives, or fruit juices, as they may reduce absorption.,Contact your doctor immediately if you develop a skin rash, hives, difficulty breathing, or swelling of the face, lips, or tongue.,Diarrhea is common; do not treat with anti-diarrhea medications without consulting your doctor, as it may indicate a more serious condition.,Inform your doctor if you are pregnant, breastfeeding, or have a history of kidney disease, asthma, or allergic reactions to any antibiotic.,This drug may reduce the effectiveness of oral contraceptives; use an additional barrier method during treatment.
Take this medication on an empty stomach, at least 1 hour before or 2 hours after meals.,Complete the entire prescribed course even if you feel better.,Inform your doctor if you develop a rash, diarrhea, or signs of an allergic reaction.,Avoid alcohol while taking ampicillin to reduce side effects.,Use effective contraception if applicable; ampicillin may reduce oral contraceptive efficacy.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about PRINCIPEN '250' vs PRINCIPEN '125', answered by our medical review team.
PRINCIPEN '250' is a Aminopenicillin Antibiotic that works by Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.. PRINCIPEN '125' is a Aminopenicillin Antibiotic that works by Ampicillin is a penicillin beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between PRINCIPEN '250' and PRINCIPEN '125' depend on the specific clinical indication. These are both Aminopenicillin Antibiotic agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of PRINCIPEN '250' is: 250 mg orally every 6 hours. The standard adult dose of PRINCIPEN '125' is: 250-500 mg orally every 6 hours for mild to moderate infections; 500 mg to 1 g every 6 hours for severe infections.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between PRINCIPEN '250' and PRINCIPEN '125' in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. PRINCIPEN '250' is classified as Category C. FDA Pregnancy Category B. Animal studies show no fetal risk, but no adequate human studies in first trimester. No known teratogenicity; use during pregnancy only if clearly needed.. PRINCIPEN '125' is classified as Category C. FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. Inadequate human data in first trimester; risk cannot be excluded. Penicillins are generally considered l. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.